May 17, 2021
The Federal Trade Commission said Monday that Arizona-based CBD company Kushly and its owner will pay $30,000 in consumer redress after an investigation revealed their deceptive marketing practices and unsubstantiated claims that CBD products could help treat Parkinson's disease, Alzheimer's disease, cancer, multiple sclerosis, hypertension and other serious ailments.
July 31, 2020
The Federal Trade Commission has asked an Arizona federal judge to force CBD company Kushly to respond to discovery requests as part of the agency's investigation into health claims the company makes about its products.